ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $181,000 | -23.9% | 21,670 | -18.7% | 0.01% | -28.6% |
| Q1 2017 | $238,000 | +17.2% | 26,638 | +15.5% | 0.01% | +40.0% |
| Q4 2016 | $203,000 | +141.7% | 23,061 | -2.5% | 0.01% | +150.0% |
| Q2 2016 | $84,000 | -47.5% | 23,641 | -56.4% | 0.00% | -60.0% |
| Q1 2016 | $160,000 | -65.6% | 54,268 | -50.8% | 0.01% | -37.5% |
| Q4 2015 | $465,000 | +440.7% | 110,271 | +487.3% | 0.01% | +700.0% |
| Q3 2015 | $86,000 | -33.8% | 18,777 | +4.1% | 0.00% | -50.0% |
| Q2 2015 | $130,000 | -65.3% | 18,043 | -64.5% | 0.00% | -75.0% |
| Q1 2015 | $375,000 | +77.7% | 50,826 | +14.1% | 0.01% | +166.7% |
| Q4 2014 | $211,000 | +95.4% | 44,562 | +46.8% | 0.00% | +50.0% |
| Q3 2014 | $108,000 | -61.6% | 30,356 | -50.9% | 0.00% | -50.0% |
| Q2 2014 | $281,000 | +215.7% | 61,826 | +227.1% | 0.00% | +300.0% |
| Q1 2014 | $89,000 | +39.1% | 18,902 | +48.7% | 0.00% | 0.0% |
| Q4 2013 | $64,000 | -54.9% | 12,715 | -44.4% | 0.00% | -50.0% |
| Q3 2013 | $142,000 | – | 22,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |